Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gasser

Showing results (281-290 of 476) with videos related to

Pageof 48
Sort By:
NPJ Parkinson'S Disease|September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seedingIsabel Wurster, Corinne Quadalti, Marcello Rossi, et al.
The Lancet. Neurology|April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesDaniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Plos One|September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot studyMichelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Journal of Neurology|March 20, 2012
Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's diseaseDaniel Weiss, Kathrin Brockmann, Karin Srulijes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's DiseaseNikolaos Papagiannakis, Hui Liu, Christos Koros, et al.
Neurology and Therapy|May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol ComparisonRoger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
BMC Neurology|March 29, 2022
Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature reviewBurcu Atasu, Ayse Nur Ozdag Acarlı, Basar Bilgic, et al.
Parkinsonism & Related Disorders|March 3, 2009
PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's diseaseAlexander Zimprich, Claudia Schulte, Eva Reinthaler, et al.
Acta Neuropathologica|November 8, 2014
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibodyWalter Maetzler, Andrea Pilotto, Anja Apel, et al.
Geroscience|June 12, 2025
Impact of lifestyle factors on quantitative motor and cognitive performance: insights from a longitudinal study on healthy ageingMilan Zimmermann, Ulrike Sünkel, Isabel Wurster, et al.
Pageof 48

Showing results (281-290 of 476) with videos related to

Sort By:
Pageof 48
NPJ Parkinson'S Disease|September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seedingIsabel Wurster, Corinne Quadalti, Marcello Rossi, et al.
The Lancet. Neurology|April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesDaniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Plos One|September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot studyMichelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Journal of Neurology|March 20, 2012
Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's diseaseDaniel Weiss, Kathrin Brockmann, Karin Srulijes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's DiseaseNikolaos Papagiannakis, Hui Liu, Christos Koros, et al.
Neurology and Therapy|May 27, 2026
Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol ComparisonRoger Plaza-Clar, Maximilian Weber, Vaibhavi Kadam, et al.
BMC Neurology|March 29, 2022
Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature reviewBurcu Atasu, Ayse Nur Ozdag Acarlı, Basar Bilgic, et al.
Parkinsonism & Related Disorders|March 3, 2009
PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's diseaseAlexander Zimprich, Claudia Schulte, Eva Reinthaler, et al.
Acta Neuropathologica|November 8, 2014
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibodyWalter Maetzler, Andrea Pilotto, Anja Apel, et al.
Geroscience|June 12, 2025
Impact of lifestyle factors on quantitative motor and cognitive performance: insights from a longitudinal study on healthy ageingMilan Zimmermann, Ulrike Sünkel, Isabel Wurster, et al.
Pageof 48